title: New drugs for treating CMV. Valcyte, an oral compound, expands the treatment options for people with CMV retinitis.
authors.forename: L
authors.initials: L
authors.lastname: Eagan
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy*; D000998:Antiviral Agents / Q000627:therapeutic use*; D017726:Cytomegalovirus Retinitis / Q000150:complications / Q000188:drug therapy*; D015774:Ganciclovir / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications; D006801:Humans; D000077562:Valganciclovir
chemical_list: D000998:Antiviral Agents; D000077562:Valganciclovir; D015774:Ganciclovir